A Review of Safety and Effectiveness of Intravenous and Intraventricular Tigecycline in Healthcare-Associated Acinetobacter baumannii Meningitis and Ventriculitis

ConclusionDespite the limited studies, IV and IVT tigecycline has been used successfully and safely for the treatment of healthcare-associatedA. baumannii meningitis and ventriculitis. However, large randomized controlled trials are necessary to clearly evaluate the safety and effectiveness of IV and IVT tigecycline in healthcare-associatedA. baumannii meningitis and ventriculitis.
Source: Current Treatment Options in Infectious Diseases - Category: Infectious Diseases Source Type: research